Mucoadhesive therapeutic compositions: a patent review (2011-2014)

References

• Song Y, Wang Y, Thakur R, et al. Mucosal drug delivery: membranes, methodologies, and applications. Crit Rev Ther Drug Carrier Syst. 2004;21(3):195–256.
   PubMedGoogle Scholar
• Serra L, Domenech J, Peppas NA. Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents. Eur J Pharm Biopharm. 2009;71(3):519–528.
   PubMed Web of Science ®Google Scholar
• Andrews GP, Laverty TP, Jones DS. Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm. 2009;71(3):505–518.
   PubMed Web of Science ®Google Scholar
• Khutoryanskiy VV. Advances in mucoadhesion and mucoadhesive polymers. Macromol Biosci. 2011;11(6):748–764.
   PubMed Web of Science ®Google Scholar
• Peppas NA. Mucoadhesive Polymers. Abstr Pap Am Chem S. 1990;199:343–POLY.
   Web of Science ®Google Scholar
• Peppas NA, Thomas JB, McGinty J. Molecular aspects of mucoadhesive carrier development for drug delivery and improved absorption. J Biomater Sci Polym Ed. 2009;20(1):1–20.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Yamamoto H, Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev. 2001;47(1):39–54.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnurch A, Walker G. Multifunctional matrices for oral peptide delivery. Crit Rev Ther Drug Carrier Syst. 2001;18(5):459–501.
   PubMed Web of Science ®Google Scholar
• Laffleur F, Bernkop-Schnurch A. Thiomers: promising platform for macromolecular drug delivery. Future Med Chem. 2012;4(17):2205–2216.
   PubMed Web of Science ®Google Scholar
• Collins LM, Dawes C. The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa. J Dent Res. 1987;66(8):1300–1302.
   PubMed Web of Science ®Google Scholar
• Galey WR, Lonsdale HK, Nacht S. The in vitro permeability of skin and buccal mucosa to selected drugs and tritiated water. J Invest Dermatol. 1976;67(6):713–717.
   PubMed Web of Science ®Google Scholar
• Laffleur F. Mucoadhesive polymers for buccal drug delivery. Drug Dev Ind Pharm. 2014;40(5):591–598.
   PubMed Web of Science ®Google Scholar
• Lee JW, Park JH, Robinson JR. Bioadhesive-based dosage forms: the next generation. J Pharm Sci. 2000;89(7):850–866.
   PubMed Web of Science ®Google Scholar
• Gandhi RB, Robinson JR. Oral cavity as a site for bioadhesive drug-delivery. Adv Drug Deliver Rev. 1994;13(12):43–74.
   Web of Science ®Google Scholar
• Harris D, Robinson JR. Drug delivery via the mucous-membranes of the oral cavity. J Pharm Sci-Us. 1992;81(1):1–10.
   PubMed Web of Science ®Google Scholar
• Sloan P, Picardo M, Schor SL. The structure and function of oral mucosa. Dent Update. 1991;18(5):208–212.
   PubMedGoogle Scholar
• Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliver Rev. 2009;61(2):158–171.
   PubMed Web of Science ®Google Scholar
• Widdicombe JH. Regulation of the depth and composition of airway surface liquid. J Anat. 2002;201(4):313–318.
   PubMed Web of Science ®Google Scholar
• Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev. 2005;57(11):1595–1639.
   PubMed Web of Science ®Google Scholar
• Robinson JR, Mlynek GM. Bioadhesive and phase-change polymers for ocular drug-delivery. Adv Drug Deliver Rev. 1995;16(1):45–50.
   Web of Science ®Google Scholar
• Hornof M, Weyenberg W, Ludwig A, et al. Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans. J Control Release. 2003;89(3):419–428.
   PubMed Web of Science ®Google Scholar
• Sultana Y, Aqil M, Ali A. Ocular inserts for controlled delivery of pefloxacin mesylate: preparation and evaluation. Acta Pharm. 2005;55(3):305–314.
   PubMedGoogle Scholar
• De Araujo Pereira RR, Bruschi ML. Vaginal mucoadhesive drug delivery systems. Drug Dev Ind Pharm. 2012;38(6):643–652.
   PubMed Web of Science ®Google Scholar
• Das Neves J, Nunes R, Machado A, et al. Polymer-based nanocarriers for vaginal drug delivery. Adv Drug Deliv Rev. 2015 Sep 15;92:53–70. doi:10.1016/j.addr.2014.12.004.
   Web of Science ®Google Scholar
• Owen DH, Katz DF. A vaginal fluid simulant. Contraception. 1999;59(2):91–95.
   PubMed Web of Science ®Google Scholar
• Valenta C. The use of mucoadhesive polymers in vaginal delivery. Adv Drug Deliv Rev. 2005;57(11):1692–1712.
   PubMed Web of Science ®Google Scholar
• Asane GS, Nirmal SA, Rasal KB, et al. Polymers for mucoadhesive drug delivery system: a current status. Drug Dev Ind Pharm. 2008;34(11):1246–1266.
   PubMed Web of Science ®Google Scholar
• Asane GS, Yamsani MR, Bhatt JH, et al. Formulation and gastrointestinal transit evaluation of mucoadhesive oral multiple unit systems of furazolidone. Lat Am J Pharm. 2010;29(8):1403–1410.
   Web of Science ®Google Scholar
• Kharenko EA, Larionova NI, Demina NB. Mucoadhesive drug delivery systems (Review). Pharm Chem J. 2009;43(4):200–208.
   Web of Science ®Google Scholar
• Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev. 2005;57(11):1556–1568.
   PubMed Web of Science ®Google Scholar
• Carvalho FC, Bruschi ML, Evangelista RC, et al. Mucoadhesive drug delivery systems. Braz J Pharm Sci. 2010;46(1):1–17.
   Web of Science ®Google Scholar
• Shaikh R, Raj Singh TR, Garland MJ, et al. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci. 2011;3(1):89–100.
   PubMed Web of Science ®Google Scholar
• Dodou D, Breedveld P, Wieringa PA. Mucoadhesives in the gastrointestinal tract: revisiting the literature for novel applications. Eur J Pharm Biopharm. 2005;60(1):1–16.
   PubMed Web of Science ®Google Scholar
• Laffleur F, Bernkop-Schnurch A. Strategies for improving mucosal drug delivery. Nanomedicine (Lond). 2013;8(12):2061–2075.
   PubMed Web of Science ®Google Scholar
• Laffleur F, Hintzen F, Rahmat D, et al. Enzymatic degradation of thiolated chitosan. Drug Dev Ind Pharm. 2013;39(10):1531–1539.
   PubMed Web of Science ®Google Scholar
• Hintzen F, Laffleur F, Sakloetsakun D, et al. In situ gelling properties of anionic thiomers. Drug Dev Ind Pharm. 2012;38(12):1479–1485.
   PubMed Web of Science ®Google Scholar
• Rahmat D, Muller C, Shahnaz G, et al. HEC-cysteamine particles: influence of particle size, zeta potential, morphology and sulfhydryl groups on permeation enhancing properties. Drug Dev Ind Pharm. 2013;39(9):1338–1345.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnurch A, Schwarz V, Steininger S. Polymers with thiol groups: a new generation of mucoadhesive polymers? Pharm Res. 1999;16(6):876–881.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnurch A. Thiomers: a new generation of mucoadhesive polymers. Adv Drug Deliver Rev. 2005;57(11):1569–1582.
   PubMed Web of Science ®Google Scholar
• Chen S, Cao Y, Ferguson LR, et al. Evaluation of mucoadhesive coatings of chitosan and thiolated chitosan for the colonic delivery of microencapsulated probiotic bacteria. J Microencapsul. 2013;30(2):103–115.
   PubMed Web of Science ®Google Scholar
• Iqbal J, Shahnaz G, Dunnhaupt S, et al. Preactivated thiomers as mucoadhesive polymers for drug delivery. Biomaterials. 2012;33(5):1528–1535.
   PubMed Web of Science ®Google Scholar
• Ijaz M, Bernkop-Schnurch A. Preactivated thiomers: their role in drug delivery. Expert Opin Drug Deliv. 2015 Aug;12(8): 1269–1281. doi:10.1517/17425247.2015.1005598.
   PubMed Web of Science ®Google Scholar
• Nowak J, Laffleur F, Bernkop-Schnurch A. Preactivated hyaluronic acid: a potential mucoadhesive polymer for vaginal delivery. Int J Pharm. 2014;478(1):383–389.
   PubMed Web of Science ®Google Scholar
• Laffleur F, Shahnaz G, Islambulchilar Z, et al. Design and in vitro evaluation of a novel polymeric excipient for buccal applications. Future Med Chem. 2013;5(5):511–522.
   PubMed Web of Science ®Google Scholar
• Abou El Ela Ael S, Khatib MM. Formulation and evaluation of new long acting metoprolol tartrate ophthalmic gels. Saudi Pharm J. 2014;22(6):555–563.
   PubMed Web of Science ®Google Scholar
• Podaralla S, Alt C, Shankar GN. Formulation development and evaluation of innovative two-polymer (SR-2P) bioadhesive vaginal gel. Aaps Pharmscitech. 2014;15(4):928–938.
   PubMed Web of Science ®Google Scholar
• Kumria R, Nair AB, Goomber G, et al. Buccal films of prednisolone with enhanced bioavailability. Drug Deliv. 2016 Feb;23(2): 471–478. doi: 10.3109/10717544.2014.920058.
   PubMed Web of Science ®Google Scholar
• Nerkar PP, Gattani SG. Oromucosal delivery of venlafaxine by linseed mucilage based gel: in vitro and in vivo evaluation in rabbits. Arch Pharm Res. 2013;36(7):846–853.
   PubMed Web of Science ®Google Scholar
• Ravi PR, Aditya N, Patil S, et al. Nasal in-situ gels for delivery of rasagiline mesylate: improvement in bioavailability and brain localization. Drug Deliv. 2015;22(7):903–910. doi: 10.3109/10717544.2013.860501.
   PubMed Web of Science ®Google Scholar
• Tartara LI, Palma SD, Allemandi D, et al. New mucoadhesive polymeric film for ophthalmic administration of acetazolamide. Recent Pat Drug Deliv Formul. 2014;8(3):224–232.
   PubMedGoogle Scholar
• Bigucci F, Abruzzo A, Vitali B, et al. Vaginal inserts based on chitosan and carboxymethylcellulose complexes for local delivery of chlorhexidine: preparation, characterization and antimicrobial activity. Int J Pharm. 2015;478(2):456–463.
   PubMed Web of Science ®Google Scholar
• Castan H, Ruiz MA, Clares B, et al. Design, development and characterization of buccal bioadhesive films of Doxepin for treatment of odontalgia. Drug Deliv. 2015.;22(6):869–876. doi:10.3109/10717544.2014.896958.
   PubMed Web of Science ®Google Scholar
• Ngwuluka NC, Choonara YE, Kumar P, et al. A novel pH-responsive interpolyelectrolyte hydrogel complex for the oral delivery of levodopa. Part I. IPEC modeling and synthesis. J Biomed Mater Res A. 2015;103(3):1077–1084.
   PubMed Web of Science ®Google Scholar
• Farid RM, Etman MA, Nada AH, et al. Formulation and in vitro evaluation of salbutamol sulphate in situ gelling nasal inserts. Aaps Pharmscitech. 2013;14(2):712–718.
   PubMed Web of Science ®Google Scholar
• Wirostko B, Mann BK, Williams DL, et al. Ophthalmic uses of a thiol-modified hyaluronan-based hydrogel. Advances in Wound Care. 2014;3(11):708–716.
   Google Scholar
• Laffleur F, Roggla J, Idrees MA, et al. Chemical modification of hyaluronic acid for intraoral application. J Pharm Sci-Us. 2014;103(8):2414–2423.
   PubMed Web of Science ®Google Scholar
• Zhang B, He D, Fan Y, et al. Oral delivery of exenatide via microspheres prepared by cross-linking of alginate and hyaluronate. Plos One. 2014;9(1):e86064.
   PubMed Web of Science ®Google Scholar
• Chen Q, Sun GB, Wang YY, et al. The evaluation of two new hyaluronan hydrogels as nasal dressing in the rabbit maxillary sinus. Am J Rhinol Allergy. 2012;26(2):152–156.
   PubMed Web of Science ®Google Scholar
• Pahuja P, Arora S, Pawar P. Ocular drug delivery system: a reference to natural polymers. Expert Opin Drug Deliv. 2012;9(7):837–861.
   PubMed Web of Science ®Google Scholar
• Li C, Han C, Zhu Y, et al. In vivo evaluation of an in-situ hydrogel system for vaginal administration. Pharmazie. 2014;69(6):458–460.
   PubMed Web of Science ®Google Scholar
• Shidhaye SS, Thakkar PV, Dand NM, et al. Buccal drug delivery of pravastatin sodium. Aaps Pharmscitech. 2010;11(1):416–424.
   PubMed Web of Science ®Google Scholar
• Li L, Wang LL, Li JF, et al. Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release. Int J Pharm. 2014;476(12):253–265.
   PubMed Web of Science ®Google Scholar
• Bertram U, Bodmeier R. Effect of polymer molecular weight and of polymer blends on the properties of rapidly gelling nasal inserts. Drug Dev Ind Pharm. 2012;38(6):659–669.
   PubMed Web of Science ®Google Scholar
• Chhonker YS, Prasad YD, Chandasana H, et al. Amphotericin-B entrapped lecithin/chitosan nanoparticles for prolonged ocular application. Int J Biol Macromol. 2015;72:1451–1458.
   PubMed Web of Science ®Google Scholar
• Andersen T, Bleher S, Eide Flaten G, et al. Chitosan in mucoadhesive drug delivery: focus on local vaginal therapy. Mar Drugs. 2015;13(1):222–236.
   PubMed Web of Science ®Google Scholar
• Prasanth VV, Puratchikody A, Mathew ST, et al. Effect of permeation enhancers in the mucoadhesive buccal patches of salbutamol sulphate for unidirectional buccal drug delivery. Res Pharm Sci. 2014;9(4):259–268.
   PubMedGoogle Scholar
• Fan B, Xing Y, Zheng Y, et al. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation. Drug Deliv. 2016 Jan;23(1):238–247. doi: 10.3109/10717544.2014.909908.
   PubMed Web of Science ®Google Scholar
• G Dehghan MH, Marzuka M. Lyophilized chitosan/xanthan polyelectrolyte complex based mucoadhesive inserts for nasal delivery of promethazine hydrochloride. Iran J Pharm Res. 2014;13(3):769–784.
   PubMed Web of Science ®Google Scholar
• Madan M, Bajaj A, Lewis S, et al. In situ forming polymeric drug delivery systems. Indian J Pharm Sci. 2009;71(3):242–251.
   PubMed Web of Science ®Google Scholar
• Pliszczak D, Bordes C, Bourgeois S, et al. Mucoadhesion evaluation of polysaccharide gels for vaginal application by using rheological and indentation measurements. Colloid Surface B. 2012;92:168–174.
   PubMed Web of Science ®Google Scholar
• Hauptstein S, Hintzen F, Muller C, et al. Development and in vitro evaluation of a buccal drug delivery system based on preactivated thiolated pectin. Drug Dev Ind Pharm. 2014;40(11):1530–1537.
   PubMed Web of Science ®Google Scholar
• Jelvehgari M, Mobaraki V, Montazam SH. Preparation and evaluation of mucoadhesive beads/discs of alginate and algino-pectinate of piroxicam for colon-specific drug delivery via oral route. Jundishapur J Nat Pharm Prod. 2014;9(4):e16576.
   PubMedGoogle Scholar
• Castile J, Cheng YH, Simmons B, et al. Development of in vitro models to demonstrate the ability of PecSys (R), an in situ nasal gelling technology, to reduce nasal run-off and drip. Drug Dev Ind Pharm. 2013;39(5):816–824.
   PubMed Web of Science ®Google Scholar
• Zhu X, Su M, Tang S, et al. Synthesis of thiolated chitosan and preparation nanoparticles with sodium alginate for ocular drug delivery. Mol Vis. 2012;18:1973–1982.
   PubMed Web of Science ®Google Scholar
• Ghosal K, Ranjan A, Bhowmik BB. A novel vaginal drug delivery system: anti-HIV bioadhesive film containing abacavir. J Mater Sci Mater Med. 2014;25(7):1679–1689.
   PubMed Web of Science ®Google Scholar
• Onishi H, Yumoto K, Sakata O. Preparation and evaluation of ritodrine buccal tablets for rational therapeutic use. Int J Pharm. 2014;468(12):207–213.
   PubMed Web of Science ®Google Scholar
• Martin MJ, Calpena AC, Fernandez F, et al. Development of alginate microspheres as nystatin carriers for oral mucosa drug delivery. Carbohyd Polym. 2015;117:140–149.
   PubMed Web of Science ®Google Scholar
• Haque S, Md S, Sahni JK, et al. Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression. J Psychiatr Res. 2014;48(1):1–12.
   PubMed Web of Science ®Google Scholar
• Alasino RV, Garcia LG, Gramajo AL, et al. Ocular biocompatibility of polyquaternium 10 gel: functional and morphological results. J Mater Sci Mater Med. 2015;26(2):5358.
   Web of Science ®Google Scholar
• Bouchemal K, Aka-Any-Grah A, Dereuddre-Bosquet N, et al. Thermosensitive and mucoadhesive pluronic(R)/hydroxypropylmethylcellulose hydrogel containing the mini CD4 M48U1 is a promising efficient barrier against HIV diffusion through macaque cervico-vaginal mucus. Antimicrob Agents Chemother. 2015 Apr;59(4):2215–2222. doi: 10.1128/AAC.03503-14.
   PubMed Web of Science ®Google Scholar
• Kumar A, Bali V, Kumar M, et al. Comparative evaluation of porous versus nonporous mucoadhesive films as buccal delivery system of glibenclamide. Aaps Pharmscitech. 2013;14(4):1321–1332.
   PubMed Web of Science ®Google Scholar
• Xu WJ, Xie HJ, Cao QR, et al. Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers. Biomol Ther (Seoul). 2014 Feb;22(2):161–165. doi:10.4062/biomolther.2013.109.
   PubMed Web of Science ®Google Scholar
• Alhalaweh A, Vilinska A, Gavini E, et al. Surface thermodynamics of mucoadhesive dry powder formulation of zolmitriptan. Aaps Pharmscitech. 2011;12(4):1186–1192.
   PubMed Web of Science ®Google Scholar
• Geethalakshmi A, Karki R, Jha SK, et al. Sustained ocular delivery of brimonidine tartrate using ion activated in situ gelling system. Curr Drug Deliv. 2012;9(2):197–204.
   PubMed Web of Science ®Google Scholar
• Patel P, Patel P. Formulation and evaluation of clindamycin HCL in situ gel for vaginal application. Int J Pharm Investig. 2015;5(1):50–56.
   PubMed Web of Science ®Google Scholar
• Remunan-Lopez C, Portero A, Vila-Jato JL, et al. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. J Control Release. 1998;55(23):143–152.
   PubMed Web of Science ®Google Scholar
• Xu H, Shi M, Liu Y, et al. A novel in situ gel formulation of ranitidine for oral sustained delivery. Biomol Ther (Seoul). 2014;22(2):161–165.
   PubMed Web of Science ®Google Scholar
• Abbas Z, Marihal S. Gellan gum-based mucoadhesive microspheres of almotriptan for nasal administration: formulation optimization using factorial design, characterization, and in vitro evaluation. J Pharm Bioallied Sci. 2014;6(4):267–277.
   PubMedGoogle Scholar
• Hauptstein S, Muller C, Dunnhaupt S, et al. Preactivated thiomers: evaluation of gastroretentive minitablets. Int J Pharm. 2013;456(2):473–479.
   PubMed Web of Science ®Google Scholar
• Millotti G, Laffleur F, Perera G, et al. In vivo evaluation of thiolated chitosan tablets for oral insulin delivery. J Pharm Sci-Us. 2014;103(10):3165–3170.
   PubMed Web of Science ®Google Scholar
• Muzib YI, Kumari KS. Mucoadhesive buccal films of glibenclamide: development and evaluation. Int J Pharm Investig. 2011;1(1):42–47.
   PubMedGoogle Scholar
• Wong CF, Yuen KH, Peh KK. Formulation and evaluation of controlled release Eudragit buccal patches. Int J Pharm. 1999;178(1):11–22.
   PubMed Web of Science ®Google Scholar
• Preis M, Woertz C, Kleinebudde P, et al. Oromucosal film preparations: classification and characterization methods. Expert Opin Drug Deliv. 2013;10(9):1303–1317.
   PubMed Web of Science ®Google Scholar
• Morales JO, McConville JT. Manufacture and characterization of mucoadhesive buccal films. Eur J Pharm Biopharm. 2011;77(2):187–199.
   PubMed Web of Science ®Google Scholar
• Mizrahi B, Domb AJ. Mucoadhesive polymers for delivery of drugs to the oral cavity. Recent Pat Drug Deliv Formul. 2008;2(2):108–119.
   PubMedGoogle Scholar
• Kumria R, Gupta V, Bansal S, et al. Oral buccoadhesive films of ondansetron: development and evaluation. Int J Pharm Investig. 2013;3(2):112–118.
   PubMedGoogle Scholar
• Das Neves J, Bahia MF. Gels as vaginal drug delivery systems. Int J Pharm. 2006;318(12):1–14.
   PubMed Web of Science ®Google Scholar
• Martin L, Wilson CG, Koosha F, et al. Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. Eur J Pharm Biopharm. 2003;55(1):35–45.
   PubMed Web of Science ®Google Scholar
• Horvat G, Gyarmati B, Berko S, et al. Thiolated poly(aspartic acid) as potential in situ gelling, ocular mucoadhesive drug delivery system. Eur J Pharm Sci. 2015;67:1–11.
   PubMed Web of Science ®Google Scholar
• Mahajan HS, Tyagi VK, Patil RR, et al. Thiolated xyloglucan: synthesis, characterization and evaluation as mucoadhesive in situ gelling agent. Carbohyd Polym. 2013;91(2):618–625.
   PubMed Web of Science ®Google Scholar
• Mangal S, Pawar D, Garg NK, et al. Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally. Vaccine. 2011;29(31):4953–4962.
   PubMed Web of Science ®Google Scholar
• Garg NK, Mangal S, Khambete H, et al. Mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymers. Recent Pat Drug Deliv Formul. 2010;4(2):114–128.
   PubMedGoogle Scholar
• Shahnaz G, Vetter A, Barthelmes J, et al. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization. Int J Pharm. 2012;428(12):164–170.
   PubMed Web of Science ®Google Scholar
• Barthelmes J, Dunnhaupt S, Unterhofer S, et al. Thiolated particles as effective intravesical drug delivery systems for treatment of bladder-related diseases. Nanomedicine (Lond). 2013;8(1):65–75.
   PubMed Web of Science ®Google Scholar
• Zambito Y, Felice F, Fabiano A, et al. Mucoadhesive nanoparticles made of thiolated quaternary chitosan crosslinked with hyaluronan. Carbohyd Polym. 2013;92(1):33–39.
   PubMed Web of Science ®Google Scholar
• Bruschi ML, De Francisco LM, SdTL A, et al. An overview of recent patents on composition of mucoadhesive drug delivery systems. Recent Pat Drug Deliv Formul. 2015;9(1):79–87.
   PubMedGoogle Scholar
• Biodelivery Sciences International, Inc., Abuse-resistant mucoadhesive devices for delivery of buprenorphine. US8703177 B2. 2014.
   Google Scholar
• Gel-Del Technologies, Inc., Mucoadhesive drug delivery devices and methods of making and using thereof. US20140107227 A1. 2014.
   Google Scholar
• The Ohio State University Research Foundation, the regents of the University of Michigan, controlled release mucoadhesive systems. US 20140056949 A1. 2014.
   Google Scholar
• Nano And Advanced Materials Institute Limited, Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery. US20130034602 A1. 2013.
   Google Scholar
• Bioalliance Pharma, Mucoadhesive buccal tablets for the treatment of orofacial herpes. WO 2011070125 A1. 2011.
   Google Scholar
• Frank G, Jones Lyndon William James, Liu Shengyan Sandy, Mucoadhesive nanoparticle delivery system. WO2013188979 A1. 2013.
   Google Scholar
• The Johns Hopkins University, Compositions and methods relating to reduced mucoadhesion. US20130236556 A1. 2013.
   Google Scholar
• Entrega, Inc., the regents of the University of California, Mucoadhesive devices for delivery of active agents. WO2013188819 A3. 2014.
   Google Scholar
• Snu R&Db Foundation, Mucoadhesive nanoform microparticles. WO2013172627 A1. 2013.
   Google Scholar
• University of Florida Research Foundation, Inc., Stephen I-Hong Hsu, Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics. CA2829241 A1. 2012.
   Google Scholar
• University of the Witwatersrand, Johannesburg, Pharmaceutical dosage form. US20130337022 A1. 2013.
   Google Scholar
• Ykk Corporation, Mucoadhesive polymers having Vitamin B partial structures. US20120225024 A1. 2012.
   Google Scholar
• Lazarus Therapeutics, Inc., Gm3 ganglioside replacement therapy. WO 2011146804 A2. 2011.
   Google Scholar
• Novartis Ag, Layered drug delivery device. WO 2011139486 A2. 2011.
   Google Scholar
• Zerbe HG, Nadine Paiement, Oral mucoadhesive dosage form. US 20110028431 A1. 2011.
   Google Scholar
• Bonengel S, Bernkop-Schnurch A. Thiomers - From bench to market. J Control Release. 2014;195:120–129.
   PubMed Web of Science ®Google Scholar